Evidence map›Paper›PMID 29322002›Full record

ArticleJournal of traditional and complementary medicine2018

Complementary and alternative medicine use in thalassemia patients in Shiraz, southern Iran: A cross-sectional study.

Mohammadreza Bordbar, Mehdi Pasalar, Sanaz Safaei, Roza Kamfiroozi, Sohelia Zareifar, Omidreza Zekavat, Sezaneh Haghpanah

Abstract read
In one paragraph

Article in Journal of traditional and complementary medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Complementary and Alternative Medicine-related Drug-induced Liver Injury in Iran.Journal of clinical and translational hepatology · 2020
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mohammadreza BordbarHematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Mehdi PasalarResearch Center for Traditional Medicine and History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Sanaz SafaeiIslamic Azad University, Isfahan (Khorasgan) Branch, Iran.
Roza KamfirooziAmir Oncology Hospital, Shiraz University of Medical Sciences, Shiraz, Iran.
Sohelia ZareifarHematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Omidreza ZekavatHematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Sezaneh HaghpanahHematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to determine the frequency and pattern of complementary and alternative medicine (CAM) use in thalassemia patients in south of Iran. The survey was done using a validated questionnaire which was distributed among 122 thalassemia patients. Only 108 questionnaires were completed and turned back (response rate 88.5%). Patients referred to an outpatient thalassemia clinic in Shiraz, southern Iran for blood transfusion. The mean age of the patients was 22.9 ± 7.9 years (range 4-45 years) with female/male ratio 1.84. Seventy four (68.5%) of the responders used CAM at least once during their life, and about half of them used it concurrently with their conventional treatments. The most reported CAM product was mint juice (50%). The most common reason of CAM use was increased general health. The most common information source about CAM was physicians who were the most trusted source as well. CAM is frequently being used in thalassemia patients to ensure their sense of well-being and help them overcome the complications of their illnesses.

Indexed as

Complementary and alternative medicineHemoglobinopathyIranThalassemiaTraditional Persian medicine

Identifiers

PMID29322002
PMCPMC5755989

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.